Gene Therapy Pioneer Jim Wilson Comments on Solid Biosciences's Announcement of FDA IND Clearance for Friedreich's Ataxia Treatment ...Middle East

PHILADELPHIA, Jan. 8, 2025 /PRNewswire/ -- Today, Dr. Jim Wilson, President and CEO of GEMMA Biotherapeutics ("GEMMABio") commented on Solid Bioscience's announcement of clearance by the Food and Drug Administration for its Investigational New Drug (IND) to treat Friedreich's ataxia (FA):...

Read More Details
Finally We wish PressBee provided you with enough information of ( Gene Therapy Pioneer Jim Wilson Comments on Solid Biosciences's Announcement of FDA IND Clearance for Friedreich's Ataxia Treatment )

Also on site :

• Brynn Whitfield Announces Exit From 'RHONY' After Two Seasons
• Born on One of These 4 Dates? You're a Wise, Old Soul
• Tony-Nominated Actress, 23, Makes Bold Declaration About Taylor Swift